NPM1 and myelodysplastic syndrome: However, the rare cases diagnosed as NPM1-mutated MDS show rapid transformation to AML [83] and respond better to CHT than to HMAs [84], suggesting that NPM1 mutations may define AML irrespective of blast percentage [85].